Loading Events

« All Events

  • This event has passed.

Texas Health CoLab Monthly Learning Series

February 28 @ 3:00 pm - 5:00 pm

Corporate Transactions for Early Stage Companies

THBD is one of four exclusive locations to live stream the Texas Health CoLab’s Monthly Learning Series. The event takes place each month at the Dell Medical School – Health Discovery Building Room. For those looking for an alternative place to view the event, closer to Temple, come by THBD to watch the event live.

Presentation Description:
Set your company up right from the start: Learn practical information and considerations that will impact the future of your work! At a Texas Health CoLab Learning Series event, hear from a panel of experts about about:
• Planning for a future transaction or exit
• Common mistakes made by early stage companies
• Engaging with potential investors or buyers
• Common due diligence issues and important issues to address in letters of intent and sale documents

About the Speakers:
Billy Murphy is a founding partner of Dwyer Murphy Calvert LLP, an Austin-based corporate law firm representing entrepreneurs, early-stage and growth companies and investors in Austin, Houston, Dallas and beyond. During his 20+ years of practice, Murphy has focused on the representation of companies and investors in a wide variety of corporate and securities law matters, including mergers and acquisitions, debt and equity financings, company formations, general corporate representation and securities issuances and compliance.

Adam Battani is an attorney with Dwyer Murphy Calvert LLP. He has practiced law for more than 20 years in a variety of law firm and business settings, including large national law firms, small transactional boutiques and general counsel roles for both an early stage internet company and a publicly traded enterprise software company. He has worked with a wide range of clients in the technology and renewable energy sectors — from established public companies to private equity owned enterprises and emerging companies developing disruptive technologies and businesses in the software, internet and e-commerce spaces.

Adam L. Berman has 20 years of experience creating and commercializing minimally-invasive medical device technologies with radical patient and health care system impact. Most recently, Berman was CEO and Co-Founder of TVA Medical, Inc. (acquired by Becton Dickinson). TVA developed a minimally-invasive AV fistula technology for patients requiring hemodialysis, which received both FDA market authorization and favorable US reimbursement from Medicare. Prior to TVA, Berman held various commercial and research and development roles at Coalescent Surgical (acquired by Medtronic), MedicalCV and Computer Motion (acquired by Intuitive Surgical), where he focused on business growth of cardiovascular anastomotic devices, laser ablation systems and robotic surgical systems.

Charlie Plauche is a Partner at S3 Ventures, an early stage venture capital firm with $450 million under management that invests in software and med-tech companies. Plauche currently serves on the boards of S3 portfolio companies Alkami Technology, OutboundEngine, Tango Health and z-lien. He also works closely with S3’s seed investments in AllStacks, BrainCheck, Chrono.gg and Liveoak Technologies. Previous board duties include Favor Delivery (acquired by H-E-B), Kimbia (acquired by GiveGab) and Pristine (acquired by Upskill). Plauche also worked closely with TVA Medical (acquired by Becton Dickinson, NYSE:BDX).